Information Systems Associates Inc. (IOSA) 0.4500

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Information Systems Associates Inc. (IOSA) 0.4500 $IOSA

ISA Duos Technologies Announces First Quarter 2015 Pro-Forma Financials
Marketwired - Wed Jun 24, 8:02AM CDT
Information Systems Associates Inc. (OTCQB: IOSA) and its wholly-owned subsidiary Duos Technologies Inc. ("Duos", a provider of intelligent security analytical technology solutions, are pleased to announce Duos' first quarter 2015 pro-forma financial results. As per its completed merger on April 1, 2015 and pursuant to the Agreement and Plan of Merger, dated February 6, 2015, Duos became a wholly-owned subsidiary of Information Systems Associates Inc. For the three months ended March 31, 2015, ISA's Duos generated $1,102,095 revenue, which represented a 4 percent increase from the first quarter of 2014.

ISA Duos Technologies Completes Integration for PPM's Perspective Incident Management Software
ACCESSWIRE - Thu Jun 18, 7:31AM CDT
Innovative Technology Expands Centraco(TM) Command and Control Platform

ISA Duos Technologies Announces Up-Listing to OTCQB Marketplace
ACCESSWIRE - Mon Jun 15, 7:30AM CDT
Upgrades Financial and Corporate Disclosure

CORRECTED: ISA's Duos Technologies Completes Critical Security Upgrade for Major Chemical Facility
ACCESSWIRE - Mon Jun 08, 10:01AM CDT
Compliant with U.S. Department of Homeland Security's Chemical Facility Anti-Terrorism Standards

ISA's Duos Technologies Completes Critical Security Upgrade for Major Chlor Alkali Facility
ACCESSWIRE - Wed Jun 03, 8:01AM CDT
Compliant with U.S. Department of Homeland Security's Chemical Facility Anti-Terrorism Standard

ISA's Duos Technologies Completes Integration of Zenitel's Stentofon IP Intercom System
ACCESSWIRE - Thu May 28, 4:51PM CDT
Innovative Technology Expands Centraco 3.0 Command and Control Platform

ISA's Duos Technologies Awarded Contract by Sheriff's Office of Monroe County, Florida
ACCESSWIRE - Tue May 26, 8:01AM CDT
Surveillance Upgrade Includes Centraco Platform

ISA's Duos Technologies Releases Third Generation Platform
ACCESSWIRE - Thu May 21, 8:01AM CDT
Innovative Technology Delivers Comprehensive Solution for Security and Enterprise Management; Ability to Offer as a SaaS Model

ISA's Duos Technologies Awarded Contract from Raytheon Intelligence, Information and Services
ACCESSWIRE - Tue May 19, 8:01AM CDT
TSA Funded Intermodal Security Program
RTN: 133.86 (+1.70)

ISA's Duos Technologies Awarded Contract from Department of Homeland Security
ACCESSWIRE - Thu May 14, 7:30AM CDT
DHS Funded Rail Undercarriage Program

Information Systems Associates Closes Merger with Duos Technologies
ACCESSWIRE - Thu Apr 02, 6:15PM CDT
CORAL SPRINGS, FL / ACCESSWIRE / April 2, 2015 / Information Systems Associates (OTC:IOSA) or ("ISA" has consummated its previously announced merger with Duos Technologies, Inc. of Jacksonville, Florida (Duos) in which Duos became a wholly owned subsidiary of Information Systems Associates. The merged entity will focus on the intelligent technologies, IT and Cloud services markets. The companies are in the process of combining operations and will continue to serve their respective customers.

Information Systems Associates Executes Merger Agreement With Duos Technologies
ACCESSWIRE - Mon Feb 09, 7:03AM CST
Closing Anticipated by March 31, 2015

Information Systems Associates to Present with Duos Technologies at The Brewer Group Conference
ACCESSWIRE - Mon Feb 02, 7:30AM CST
CORAL SPRINGS, FL / ACCESSWIRE / February 2, 2015 / Information Systems Associates (OTC: IOSA) or ("ISA" will be presenting at The Brewer Group "Innovations" conference in Miami Beach, Florida on February 9, 2015. The presentation will be in conjunction with Duos Technologies of Jacksonville, Florida. In December 2014, the Companies announced the signing of a Letter of Intent to merge and have been actively working towards signing the definitive Merger Agreement and closing subject to complying with all regulatory requirements. Closing is expected to occur by March 31, 2015.

Information Systems Associates Announces Letter of Intent to Merge with DUOS Technologies
ACCESSWIRE - Wed Dec 10, 9:05AM CST
CORAL SPRINGS, FL / ACCESSWIRE / December 10, 2014 / Information Systems Associates (OTC Markets: IOSA) or ("ISA" has entered into a non-binding letter of intent to merge with Duos Technologies, Inc. ("DUOS", a privately held advanced intelligent technologies company headquartered in Jacksonville Florida. The merger will be structured as a reverse triangular merger. Each company's Board of Directors has unanimously approved the letter of intent.

Information Systems Associates Acquires 3% Stake in Schlep2p International
Marketwired - Wed Nov 12, 6:59AM CST
Information Systems Associates (OTCQB: IOSA) has executed a definitive agreement with Schlep2p International LLC (Schlep) and completed its acquisition of a 3% ownership interest in Schlep. The companies had previously announced that they had executed a term sheet calling for collaboration in a variety of areas including technical, financial and managerial oversight. In addition to the minority stake, ISA has secured an option to acquire all of the remaining technology and intellectual property rights of Schlep for $3.23M in cash and/or preferred stock of ISA. Schlep is developing a friendship-based ride-sharing platform where friends can share rides with nearby friends at the tap of a button on their mobile devices. Recently, ride-sharing companies like Uber and Lyft have been growing exponentially across the country and abroad.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Updated Category News Views 40

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 273

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 240

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 167

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 0

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 121

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 120

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 184

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Updated Category News Views 208

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 135

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading

Top 5 Most Recently Viewed Articles

MAAS Embraces Healthcare with Strategic Carve Group Acquisition

Updated Category News Views 117

MAAS Expands into Healthcare and Wellness Maase Inc. (NASDAQ: MAAS) recently announced a significant expansion into the healthcare and wellness sector following its acquisition of Carve Group Ltd. This strategic move signifies MAAS's commitment to innovate within the traditional wellness product landscape by integrating advanced biotechnology. The acquisition is more than...

Continue Reading
Metavesco Welcomes ADHC's Strategic Purchase of OTCfi Tokens

Updated Category News Views 117

Metavesco Celebrates Collaboration with ADHC In a significant development, Metavesco, Inc. (NASDAQ: MVCO) recently expressed excitement over American Diversified Holdings Corporation (NASDAQ: ADHC) announcing their Digital Asset Treasury (DAT) purchase of OTCfi tokens. This partnership is seen as a positive move towards enhancing the visibility and growth of the...

Continue Reading
Understanding Short Interest Trends in Discover Financial

Updated Category News Views 188

Understanding Short Interest Trends in Discover Financial Discover Financial's stock ticker, DFS, has recently experienced an increase in its short interest, rising to 10.94% since the last report. The total number of shares sold short now stands at 3.11 million, equating to 1.42% of the available shares for trading. If we consider the current trading volume, it would...

Continue Reading
Immunic Reaches Key Milestone in Multiple Sclerosis Trials

Updated Category News Views 201

Immunic Completes Enrollment in Phase 3 Trials Immunic, Inc. (NASDAQ: IMUX), a pioneering biotechnology firm, recently reached a significant milestone by completing enrollment for its Phase 3 ENSURE trials, which focus on its lead drug, vidofludimus calcium. These trials target patients living with relapsing multiple sclerosis (RMS) and aim to evaluate the drug's...

Continue Reading
Ergonomic Apparel Revolution: Elevating Back Health in Daily Life

Updated Category News Views 86

Rising Trend of Ergonomic Posture Wear The growing trend of ergonomic apparel highlights the importance of posture-related health concerns. As people spend more time seated and engaged with screens, discomfort is becoming increasingly common. A recent review has brought attention to this phenomenon, shedding light on how ergonomic clothing can play a pivotal role in...

Continue Reading